Cited by 355Gastrointestinal motility and disordersGut microbiota and healthInflammatory Bowel Disease

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Altered 5-Hydroxytryptamine Signaling in Patients With Constipation- and Diarrhea-Predominant Irritable Bowel Syndrome

Open access

Atkinson, Wendy, Lockhart, Stephen, Whorwell, Peter J., Keevil, Brian, Houghton, Lesley A.·2006·Gastroenterology

DOI 10.1053/j.gastro.2005.09.031

Open this paper in CoChat — free account Open PDF

Abstract

Background & aims Evidence suggests that postprandial platelet-depleted plasma 5-hydroxytryptamine (5-HT) concentrations may be abnormal in irritable bowel syndrome (IBS). However, interpretation of the data has been hampered by the variable methodology and rather small numbers used in previous studies. Therefore, the aim of this study was to measure concentrations of platelet-depleted plasma 5-HT and its metabolite 5-HIAA under fasting and fed conditions in a large group of patients with diarrhea-predominant (d-) and constipation-predominant (c-) IBS, compared with controls. The ratio of plasma 5-HIAA:5-HT and platelet stores was also assessed.Methods Twenty-nine c-IBS patients (aged, 19-53 years), 55 d-IBS patients (aged, 19-52 years), and 35 healthy volunteers (aged, 18-46 years) had platelet-depleted plasma 5-HT/5-HIAA concentrations measured using reverse-phase, high-performance liquid chromatography with fluorimetric detection before and after a standard meal.Results d-IBS patients had raised platelet-depleted plasma 5-HT concentrations under fasting and fed conditions (P < .05). However, the postprandial relative to fasting concentration was similar to controls. In contrast, c-IBS patients failed to show an increase in platelet-depleted plasma 5-HT concentration with meal ingestion compared with controls (P < .01). c-IBS was associated with decreased 5-HIAA (P < .01) but normal 5-HIAA:5-HT ratio and d-IBS with normal 5-HIAA concentrations but reduced 5-HIAA:5-HT ratio (P < .005). C-IBS but not d-IBS patients had increased platelet 5-HT.Conclusions These results support the concept that d-IBS is characterized by reduced 5-HT reuptake, whereas impaired release may be a feature of c-IBS. These results also provide a rational basis for current pharmacologic approaches involving modulation of different 5-HT receptors in c- and d-IBS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2005.09.031

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome 1 ☆
Coates, M. D., Mahoney, C. R., Linden, D. R., Sampson, J. E., Chen, J. C., Blaszyk, H., Crowell, M. D., Sharkey, K. A., Gershon, M. D., & Mawe, G. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.013 · Cited by 761
Serotonin: A Mediator of The Brain–Gut Connection
Kim, D.-Y., & Camilleri, M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03177.x · Cited by 448
Cocaine, Ethanol, and Genotype Effects on Human Midbrain Serotonin Transporter Binding Sites and mRNA Levels
Little, K. Y., McLaughlin, D. P., Zhang, L., Livermore, C. S., Dalack, G. W., McFinton, P. R., DelProposto, Z., Hill, E. M., Cassin, B. J., Watson, S. J., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.207 · Cited by 382
Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns.
Cann, P. A., Read, N. W., Brown, C., Hobson, N., & Holdsworth, C. D. (1983) · Gut · doi:10.1136/gut.24.5.405 · Cited by 365
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome
Dunlop, S. P., Coleman, N. S., Blackshaw, E., Perkins, A. C., Singh, G., Marsden, C. A., & Spiller, R. E. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00726-8 · Cited by 355
Colonic Motility Abnormality in Patients With Irritable Bowel Syndrome Exhibiting Abdominal Pain and Diarrhea
Chey, W. Y., Jin, H. O., Lee, M. H., Sun, S. W., & Lee, K. Y. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03804.x · Cited by 347
The motility of the pelvic colon
Connell, A. M. (1962) · Gut · doi:10.1136/gut.3.4.342 · Cited by 315
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study
Bearcroft, C. P., Perrett, D. I., & Farthing, M. J. G. (1998) · Gut · doi:10.1136/gut.42.1.42 · Cited by 303

Flagged first, then by citations

Show all 41 references

Research works printed but not linked: 1

Whitaker, 1996, Measurement of platelet rich plasma 5-HT and platelet poor plasma 5-HIAA and 5-HT in normal adults, Ann Clin Biochem, 537, 341

Sorted by citations

Items 101–200 of 355

Anxiety, depression and distress among irritable bowel syndrome and their subtypes: An epidemiological population based study
Roohafza, H., Bidaki, E. Z., Keshteli, A. H., Daghaghzade, H., Afshar, H., & Adibi, P. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.190938 · Cited by 48
The genetics of the serotonin transporter and irritable bowel syndrome
Colucci, R., Blandizzi, C., Bellini, M., Ghisu, N., Tonini, M., & Tacca, M. D. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.05.001 · Cited by 48
Traditional Thoughts on the Pathophysiology of Irritable Bowel Syndrome
Hasler, W. L. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.004 · Cited by 46
Serotonin receptor modulators in the treatment of irritable bowel syndrome
Lackner, J. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s140 · Cited by 47
Sigmoid‐colonic motility in health and irritable bowel syndrome: a role for 5‐hydroxytryptamine
Houghton, L. A., Atkinson, W., Lockhart, S., Fell, C., Whorwell, P. J., & Keevil, B. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00943.x · Cited by 46
Self-citation
Pharmacogenetics of Drugs Withdrawn from the Market
Zhang, W., Roederer, M. W., Chen, W., Fan, L., & Zhou, H.-H. (2012) · Pharmacogenomics · doi:10.2217/pgs.11.137 · Cited by 46
Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome
Camilleri, M. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.261 · Cited by 47
Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?
Camilleri, M., Halawi, H., & Oduyebo, I. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1288096 · Cited by 45
The gut microbiome and irritable bowel syndrome: State of art review
Salem, A., Singh, R., Ayoub, Y. K., Khairy, A. M., & Mullin, G. E. (2018) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2018.02.008 · Cited by 45
Serotonin, Inflammation, and IBS: Fitting the Jigsaw Together?
Spiller, R. E. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31812e66da · Cited by 44
Functional Constipation: Individualising Assessment and Treatment
Pannemans, J., Masuy, I., & Tack, J. (2020) · Drugs · doi:10.1007/s40265-020-01305-z · Cited by 46
Irritable Bowel Syndrome
Mullin, G. E., Shepherd, S. J., Roland, B. C., Ireton-Jones, C. S., & Matarese, L. E. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114545329 · Cited by 47
Association between functional gastrointestinal disorders and migraine in children and adolescents: a case-control study
Gal, J. L., Michel, J., Rinaldi, V. E., Spiri, D., Moretti, R., Bettati, D., Romanello, S., Berlese, P., Lualdi, R., Boizeau, P., et al. (2016) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30038-3 · Cited by 44
Abnormalities of mucosal serotonin metabolism and 5‐HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron
Gunn, D., Garsed, K., Lam, C., Singh, G., Lingaya, M., Wahl, V., Niesler, B., Henry, A., Hall, I., Whorwell, P., et al. (2019) · Alimentary Pharmacology and Therapeutics · doi:10.1111/apt.15420 · Cited by 41
Self-citation
Progesterone receptors and serotonin levels in colon epithelial cells from females with slow transit constipation
Guarino, M. P. L., Cheng, L., Cicala, M., Ripetti, V., Biancani, P., & Behar, J. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01705.x · Cited by 43
Retracted
Intestinal Secretory Mechanisms in Irritable Bowel Syndrome–Diarrhea
Camilleri, M. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.020 · Cited by 43
Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis
Luo, M., Zhuang, X., Tian, Z., & Xiong, L. (2021) · BMC Gastroenterology · doi:10.1186/s12876-020-01577-5 · Cited by 45
Low anterior resection syndrome
Ryoo, S. (2023) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12695 · Cited by 41
Visceral hypersensitivity in irritable bowel syndrome: evidence for involvement of serotonin metabolism – a preliminary study
Keszthelyi, D., Troost, F. J., Jonkers, D. M. A. E., van Eijk, H. M. H., Dekker, J. P., Buurman, W. A., & Masclee, A. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12600 · Cited by 41
Hesperidin Improves Colonic Motility in Loeramide-Induced Constipation Rat Model via 5-Hydroxytryptamine 4R/cAMP Signaling Pathway
Wu, M., Li, Y., & Gu, Y. (2019) · Digestion · doi:10.1159/000501959 · Cited by 41
Linking serotonin homeostasis to gut function: Nutrition, gut microbiota and beyond
Jiang, L., Han, D., Hao, Y., Song, Z., Sun, Z., & Dai, Z. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2183935 · Cited by 45
Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome
Jun, S., Kohen, R., Cain, K. C., Jarrett, M. E., & Heitkemper, M. M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01623.x · Cited by 41
An update on irritable bowel syndrome: from diagnosis to emerging therapies
CHANG, J. Y., & Talley, N. J. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283414065 · Cited by 42
Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome
Zou, B., Dong, L., Wang, Y., Wang, S., & Ming-bo, C. A. O. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200712010-00002 · Cited by 40
Gut Microbial Metabolites and Biochemical Pathways Involved in Irritable Bowel Syndrome: Effects of Diet and Nutrition on the Microbiome
James, C. S., Fraser, K., Young, W., McNabb, W. C., & Roy, N. C. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz302 · Cited by 41
Tryptophan Hydroxylase Autoantibodies as Markers of a Distinct Autoimmune Gastrointestinal Component of Autoimmune Polyendocrine Syndrome Type 1
Scarpa, R., Alaggio, R., Norberto, L., Furmaniak, J., Chen, S., Smith, B. R., Masiero, S., Morlin, L., Plebani, M., Luca, F. D., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2734 · Cited by 38
Latest Insights on the Pathogenesis of Irritable Bowel Syndrome
Videlock, E. J., & Chang, L. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.04.002 · Cited by 38
Changes in Tryptophan Metabolism on Serotonin and Kynurenine Pathways in Patients with Irritable Bowel Syndrome
Chojnacki, C. J., Błońska, A., Konrad, P., Chojnacki, M., Podogrocki, M., & Popławski, T. (2023) · Nutrients · doi:10.3390/nu15051262 · Cited by 40
Abnormal accumulation of intestinal fluid following ingestion of an unabsorbable carbohydrate in patients with irritable bowel syndrome: an MRI study
Undseth, R., Berstad, A., Kløw, N., Arnljot, K., Moi, K. S., & Valeur, J. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12449 · Cited by 37
Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions
Camilleri, M., Oduyebo, I., & Halawi, H. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00242.2016 · Cited by 38
Serotonin transporter activity and serotonin concentration in platelets of patients with irritable bowel syndrome: effect of gender
Franke, L., Schmidtmann, M., Riedl, A., van der Voort, I., Uebelhack, R., & Mönnikes, H. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0167-y · Cited by 35
Gut microbiota and intestinal immunity—A crosstalk in irritable bowel syndrome
Chen, Y., Feng, S., Li, Y., Zhang, C., Chao, G., & Zhang, S. (2024) · Immunology · doi:10.1111/imm.13749 · Cited by 36
Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.
Camilleri, M., & Ford, A. (2017) · Handbook of Experimental Pharmacology · doi:10.1007/164_2016_102 · Cited by 33
A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
Khalilian, A., Ahmadimoghaddam, D., Saki, S., Mohammadi, Y., & Mehrpooya, M. (2021) · BioPsychoSocial Medicine · doi:10.1186/s13030-021-00205-2 · Cited by 36
Postinfectious Irritable Bowel Syndrome: A Long-Term Consequence of Bacterial Gastroenteritis
Smith, J. L., & Bayles, D. O. (2007) · Journal of Food Protection · doi:10.4315/0362-028x-70.7.1762 · Cited by 33
Measurement of serotonin in platelet depleted plasma by liquid chromatography tandem mass spectrometry
Monaghan, P. J., Brown, H. A., Houghton, L. A., & Keevil, B. G. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.05.045 · Cited by 33
Self-citation
Molecular basis of the irritable bowel syndrome
Vaiopoulou, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i2.376 · Cited by 33
Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome
Ding, Y., Lu, B., Chen, D., Meng, L.-N., Shen, Y., & Chen, S. (2010) · PROTEOMICS · doi:10.1002/pmic.200900572 · Cited by 33
Mechanisms Underlying Food-Triggered Symptoms in Disorders of Gut-Brain Interactions
den Houte, K. V., Berčík, P., Simrén, M., Tack, J. F., & Vanner, S. J. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001812 · Cited by 40
The effects of Fructus Aurantii extract on the 5-hydroxytryptamine and vasoactive intestinal peptide contents of the rat gastrointestinal tract
Jiang, Y., Bai, X., Zhu, X., & Li, J. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2013.854396 · Cited by 32
Irritable bowel syndrome with constipation: a European-focused systematic literature review of disease burden
Fortea, J., & Prior, M. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2012.756397 · Cited by 33
The trace aminergic system: a gender-sensitive therapeutic target for IBS?
Pretorius, L., & Smith, C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00688-1 · Cited by 32
The role of serotonin and diet in the prevalence of irritable bowel syndrome: a systematic review
Bruta, K., Vanshika, Bhasin, K., & Bhawana, B. (2021) · Translational Medicine Communications · doi:10.1186/s41231-020-00081-y · Cited by 34
Identification of a Functional TPH1 Polymorphism Associated With Irritable Bowel Syndrome Bowel Habit Subtypes
Grasberger, H., Chang, L., Shih, W., Presson, A. P., Sayuk, G. S., Newberry, R. D., Karagiannides, I., Pothoulakis, C., Mayer, E. A., & Merchant, J. L. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.304 · Cited by 32
Elevated expression of c-fos in central nervous system correlates with visceral hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS treatment
Zhang, R., Zou, N., Li, J., Lv, H., Wei, J., Fang, X., & Qian, J. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1153-4 · Cited by 32
O EIXO INTESTINO-CÉREBRO E O PAPEL DA SEROTONINA
Vedovato, K., Trevizan, A. R., Zucoloto, C. N., Bernardi, M. D. L., Zanoni, J. N., & Martins, J. V. C. (2015) · Arquivos de Ciências da Saúde da UNIPAR · doi:10.25110/arqsaude.v18i1.2014.5156 · Cited by 31
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents
Sainsbury, A., & Ford, A. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x10387203 · Cited by 36
Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials
Shah, E. D., Lacy, B. E., Chey, W. D., Chang, L., & Brenner, D. M. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001313 · Cited by 31
The Effects of Eupatilin (Stillen®) on Motility of Human Lower Gastrointestinal Tracts
Ryoo, S., Oh, H., Yu, S. A., Moon, S. H., Choe, E. K., Oh, T. Y., & Park, K. J. (2014) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2014.18.5.383 · Cited by 31
5‐hydroxytryptamine signalling in irritable bowel syndrome with diarrhoea: effects of gender and menstrual status
Houghton, L. A., BROWN, H., Atkinson, W., Morris, J., Fell, C., Whorwell, P. J., Lockhart, S. N., & Keevil, B. G. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04121.x · Cited by 31
Self-citation
Serotonergic agents and the irritable bowel syndrome: what goes wrong?
Spiller, R. E. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.07.003 · Cited by 30
Genetic polymorphism in pathogenesis of irritable bowel syndrome
Cheung, C., & Wu, J. C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17693 · Cited by 29
Anterior resection syndrome: a randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer
Ryoo, S. B., Park, J.-W., Lee, D. W., Lee, M.-C., Kwon, Y. H., Kim, M. J., Moon, S. H., Jeong, S. Y., & Park, K. J. (2021) · British journal of surgery · doi:10.1093/bjs/znab071 · Cited by 28
Lower urinary tract symptoms in women with irritable bowel syndrome
Guo, Y., Ho, C., Chen, S., Yang, S., Chiu, H., & Huang, K. (2010) · International Journal of Urology · doi:10.1111/j.1442-2042.2009.02442.x · Cited by 28
Decreased Basal and Postprandial Plasma Serotonin Levels in Patients With Functional Dyspepsia
Cheung, C., Lee, Y. Y., Chan, Y., Cheong, P. K., Law, W. T., Lee, S. F., Sung, J. J. �., Chan, F. K. L., & Wu, J. C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.03.026 · Cited by 28
An evidence-based update on the diagnosis and management of irritable bowel syndrome
Black, C. J., & Ford, A. C. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2455586 · Cited by 27
Serotonergic Control of Gastrointestinal Development, Motility, and Inflammation
Najjar, S. A., Hung, L. Y., & Margolis, K. G. (2023) · Comprehensive physiology · doi:10.1002/j.2040-4603.2023.tb00272.x · Cited by 27
2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome
Choi, Y., Youn, Y. H., Kang, S. J., Shin, J. E., Cho, Y. S., Jung, Y. S., Shin, S. Y., Huh, C. W., Lee, Y. J., Koo, H. S., et al. (2025) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm25007 · Cited by 36
Electroacupuncture versus Moxibustion for Irritable Bowel Syndrome: A Randomized, Parallel-Controlled Trial
Shi, Y., Yue-hua, C., Yin, X.-J., Wang, A.-Q., Chen, X.-K., Lu, J., Ji, R., Bao, C., Sun, J., Zhao, J., et al. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/361786 · Cited by 26
Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open‐label, non‐inferiority, randomized controlled study
Sohn, W., Lee, O. Y., Kwon, J. G., Park, K. S., Lim, Y. J., Kim, T. H., Jung, S., & Kim, J. I. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01945.x · Cited by 26
Identification of human gut bacteria that produce bioactive serotonin and promote colonic innervation
Moretti, C. H., Grasset, E., Zhu, J., Yang, G., Olofsson, L. E., Khan, M. T., Bergh, P., Oh, J., Lundqvist, A., Gils, T. V., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116434 · Cited by 32
Influence of a new 5‐ HT 4 receptor partial agonist, YKP 10811, on visceral hypersensitivity in rats triggered by stress and inflammation
Gilet, M., Eutamène, H., Han, H. S., Kim, H., & Bueno, L. P. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12458 · Cited by 25
Diet differentially regulates enterochromaffin cell serotonin content, density and nutrient sensitivity in the mouse small and large intestine
Martin, A. M., Jones, L. A., Jessup, C. F., Sun, E. W. L., & Keating, D. J. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13869 · Cited by 25
Association Study of Serotonin Transporter SLC6A4 Gene with Chinese Han Irritable Bowel Syndrome
Yuan, J., Kang, C., Wang, M., Wang, Q., Li, P., Liu, H., Hou, Y., Su, P., Yang, F., Wei, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084414 · Cited by 25
Metabolic Kinetics of 5-Hydroxytryptamine and the Research Targets of Functional Gastrointestinal Disorders
Jing, F., & Zhang, J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3244-x · Cited by 25
Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity.
Yang, Y., Cui, X., Chen, Y., Wang, Y., Li, X., Lin, L., & Zhang, H. (2014) · PubMed · Cited by 25
Recent advances in pharmacological treatment of irritable bowel syndrome.
Geórgia, Lazaraki, Grigoris, Chatzimavroudis, Panagiotis, & Katsinelos (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i27.8867 · Cited by 30
Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation
Videlock, E. J., Mahurkar‐Joshi, S., Hoffman, J. M., Iliopoulos, D., Pothoulakis, C., Mayer, E. A., & Chang, L. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00288.2017 · Cited by 25
Serotonergic Control of Gastrointestinal Development, Motility, and Inflammation
Najjar, S. A., Hung, L. Y., & Margolis, K. G. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220024 · Cited by 53
Partial Agonism of 5-HT3Receptors: A Novel Approach to the Symptomatic Treatment of IBS-D
Moore, N. A., Sargent, B. J., Manning, D. D., & Guzzo, P. R. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300166c · Cited by 24
FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats
Akiba, Y., Maruta, K., Narimatsu, K., Said, H., Kaji, I., Kuri, A., Iwamoto, K., Kuwahara, A., & Kaunitz, J. D. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00041.2017 · Cited by 24
Colorimetry and SERS dual-mode sensing of serotonin based on functionalized gold nanoparticles
Wang, W., Zhang, B., Zhang, Y., Ma, P., Wang, X., Sun, Y. X., Song, D., & Fei, Q. (2021) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2021.120057 · Cited by 23
Physiological mechanisms of unexplained (functional) gastrointestinal disorders
Burns, G. L., Hoedt, E. C., Walker, M. M., Talley, N. J., & Keely, S. (2021) · The Journal of Physiology · doi:10.1113/jp281620 · Cited by 23
Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome.
Katiraei, P., & Bultron, G. (2011) · PubMed Central · doi:10.3748/wjg.v17.i23.2791 · Cited by 27
The Role ofH. pyloriCagA in Regulating Hormones of Functional Dyspepsia Patients
Meng, W. P., Wang, Z., Deng, J., Liu, Y., Deng, M., & Lü, M.-H. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/7150959 · Cited by 23
Effects of vitamin D3 supplementation on clinical symptoms, quality of life, serum serotonin (5-hydroxytryptamine), 5-hydroxy-indole acetic acid, and ratio of 5-HIAA/5-HT in patients with diarrhea-predominant irritable bowel syndrome: A randomized clinical trial
Sikaroudi, M. K., Mokhtare, M., Shidfar, F., Janani, L., Kashani, A. F., Masoodi, M., Agah, S., Dehnad, A., & Shidfar, S. (2020) · EXCLI journal · doi:10.17179/excli2020-2247 · Cited by 27
Seroprevalence of Hepatitis A and E Virus Infections Among Healthy Population in Shiraz, Southern Iran
Asaei, S., Ziyaeyan, M., Moeini, M., Jamalidoust, M., & Behzadi, M. A. (2015) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.19311v2 · Cited by 23
Probiotic use in irritable bowel syndrome
Young, P., & Cash, B. D. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0053-1 · Cited by 22
Gastrointestinal pathophysiology in long COVID: Exploring roles of microbiota dysbiosis and serotonin dysregulation in post-infectious bowel symptoms
Yu, L. C. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123153 · Cited by 29
Unraveling the Pathophysiology of Irritable Bowel Syndrome: Mechanisms and Insights
Aggeletopoulou, I., Papantoniou, K., Pastras, P., & Triantos, C. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110598 · Cited by 25
The Crucial Role of the Interstitial Cells of Cajal in Neurointestinal Diseases
Choi, E. L., Taheri, N., Tan, E., Matsumoto, K., & Hayashi, Y. (2023) · Biomolecules · doi:10.3390/biom13091358 · Cited by 23
Emerging Pharmacological Therapies for the Irritable Bowel Syndrome
Maneerattanaporn, M., Chang, L., & Chey, W. D. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.002 · Cited by 21
Bisphenol A (BPA)-Induced Changes in the Number of Serotonin-Positive Cells in the Mucosal Layer of Porcine Small Intestine—the Preliminary Studies
Gonkowski, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031079 · Cited by 22
Recent developments in the therapy of irritable bowel syndrome
Saad, R. J., & Chey, W. D. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.117 · Cited by 21
Olanzapine May Inhibit Colonic Motility Associated with the 5-HT Receptor and Myosin Light Chain Kinase
Zhang, J., Qiao, Y., Le, J., Sun, D., Guan, Y., & Li, Z. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.2.232 · Cited by 20
Female serotonin transporter‐knockout rat: A potential model of irritable bowel syndrome
Bi, Z., Zhang, S., Meng, Y., Feng, Y., Wang, Y., Wang, E., Pan, X., Zhu, R., Fan, H., Pang, S., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202000007rrr · Cited by 20
Pathogenesis and management of irritable bowel syndrome.
Mathew, P., & Bhatia, S. J. (2009) · PubMed · Cited by 20
Phase II drugs under clinical investigation for the treatment of chronic constipation
Mozaffari, S., Didari, T., Nikfar, S., & Abdollahi, M. R. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.932770 · Cited by 20
Chronic Pain Treatment: The Influence of Tricyclic Antidepressants on Serotonin Release and Uptake in Mast Cells
Ferjan, I., & Lipnik‐Štangelj, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/340473 · Cited by 21
Does co‐administration of a non‐selective opiate antagonist enhance acceleration of transit by a 5‐HT4 agonist in constipation‐predominant irritable bowel syndrome? A randomized controlled trial
Foxx–Orenstein, A. E., Camilleri, M., Szarka, L. A., McKinzie, S., Burton, D. D., Thomforde, G. M., Baxter, K. L., & Zinsmeister, A. R. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00944.x · Cited by 20
Loss of autism-candidate CHD8 perturbs neural crest development and intestinal homeostatic balance
Hayot, G., Massonot, M., Keime, C., Faure, E., & Golzio, C. (2022) · Life Science Alliance · doi:10.26508/lsa.202201456 · Cited by 19
A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites
Chojnacki, C. J., Mędrek-Socha, M., Błońska, A., Zajdel, R., Chojnacki, J., & Popławski, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315314 · Cited by 19
Schisandra chinensis reverses visceral hypersensitivity in a neonatal–maternal separated rat model
Yang, J.-M., Xian, Y., Ip, S., Wu, J. C., Lao, L., Fong, H. H. S., Sung, J. J. �., Berman, B., Yeung, J. H. K., & Che, C. (2012) · Phytomedicine · doi:10.1016/j.phymed.2011.11.013 · Cited by 19
What’s New in the Toolbox for Constipation and Fecal Incontinence?
Lee, Y. Y. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00005 · Cited by 19
Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome
Mozaffari, S., Nikfar, S., & Abdollahi, M. R. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.759558 · Cited by 20
Changes in salivary physiological stress markers induced by muscle stretching in patients with irritable bowel syndrome
Hamaguchi, T., Fukudo, S., Kanazawa, M., Tomiie, T., Shimizu, K., Oyama, M., & Sakurai, K. (2008) · BioPsychoSocial Medicine · doi:10.1186/1751-0759-2-20 · Cited by 19
Genetics and Pharmacogenetics of Aminergic Transmitter Pathways in Functional Gastrointestinal Disorders
Martinucci, I., Blandizzi, C., de Bortoli, N., Bellini, M., Antonioli, L., Tuccori, M., Fornai, M., Marchi, S., & Colucci, R. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.12 · Cited by 19
Stem Cells in the Intestine: Possible Roles in Pathogenesis of Irritable Bowel Syndrome
Ratanasirintrawoot, S., & Israsena, N. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16023 · Cited by 19
Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation
von Volkmann, H. L., Brønstad, I., Gilja, O. H., Tronstad, R. R., Sangnes, D. A., Nortvedt, R., Hausken, T., Dimcevski, G., Fiskerstrand, T., & Nylund, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185496 · Cited by 19
Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats.
Chen, M., Chen, Y., Fu, R., Liu, S.-Y., Yang, Q., & Shen, T.-B. (2016) · PubMed Central · Cited by 19

Authors: Atkinson, W., Lockhart, S., Whorwell, P. J., Keevil, B., & Houghton, L. A.
Corresponding author: Houghton, Lesley A.
ORCID: Whorwell, Peter J.
Keevil, Brian
Houghton, Lesley A.
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2006-01
Volume: 130
Issue: 1
Pages: 34-43
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2005.09.031
OpenAlex: W2128077096
Cited by: 355
References: 41
Citations by year: 2026: 10 · 2025: 11 · 2024: 15 · 2023: 21 · 2022: 20 · 2021: 30 · 2020: 18 · 2019: 12 · 2018: 11 · 2017: 15 · 2016: 15 · 2015: 12 · 2014: 30 · 2013: 16 · 2012: 20
FWCI: 18.47
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (publishedVersion, other-oa)
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Keywords: irritable bowel syndrome, irritable bowel syndrome with constipation, diarrhea-predominant irritable bowel syndrome, serotonin, 5-hydroxyindoleacetic acid, serotonin uptake, serotonin release, serotonin receptors
MeSH terms: Adult, Chromatography, High Pressure Liquid, Constipation, Diarrhea, Fasting, Female, Humans, Hydroxyindoleacetic Acid, Male, Middle Aged, Serotonin, Signal Transduction, Case-Control Studies, Postprandial Period, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Altered 5-Hydroxytryptamine Signaling in Patients With Constipation- and Diarrhea-Predominant Irritable Bowel Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks